Erlotinib/gefitinibAcneiform eruption: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1441卷 / 1期

关键词：

D O I：

10.1007/s40278-013-1646-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：15 / 15

相关论文

共 50 条

[21] Erlotinib/gefitinib/osimertinibAcquired drug resistance: 3 case reports
Reactions Weekly, 2019, 1752 (1) : 158 - 158
[22] AntibacterialsRecurrent fixed drug eruption: 3 case reports
Reactions Weekly, 2018, 1733 (1) : 48 - 48
[23] Mefenamic acidFixed drug eruption: 3 case reports
Reactions Weekly, 2011, 1356 (1) : 24 - 24
[24] Erlotinib/gefitinibHepatotoxicity: 8 case reports
Reactions Weekly, 2013, 1440 (1) : 17 - 17
[25] Erlotinib/navitoclaxDehydration, diarrhoea, hypotensive syncope and nausea: 3 case reports
Reactions Weekly, 2015, 1581 (1) : 144 - 144
[26] Crizotinib/erlotinib/gefitinibElevated liver aminotransferase and nausea: 3 case reports
Reactions Weekly, 2019, 1748 (1) : 149 - 149
[27] Cobimetinib/selumetinib/trametinibDrug hypersensitivity eruption: 3 case reports
Reactions Weekly, 2015, 1538 (1) : 81 - 81
[28] TerbinafineLupus erythematosus-like eruption: 3 case reports
Reactions Weekly, 2003, 963 (1) : 15 - 15
[29] Potassium bromideVomiting, drowsiness and acneiform eruption: 3 case reports
Reactions Weekly, 2015, 1553 (1) : 246 - 246
[30] Potassium bromideVomiting, drowsiness and acneiform eruption: 3 case reports
Reactions Weekly, 2014, 1528 (1) : 174 - 174

← 1 2 3 4 5 →